secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMARIN CORP PLCUK (AMRN)
CIK:        0000897448
Form:       8-K
Filed at:   2023-01-10T23:59:59+00:00
Accession:  0001193125-23-005176
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amarin appoints Murray Stewart to Board; 75% of directors new in last 12 months
-------------------------------------------------------------------------------

- Murray Stewart, DM FRCP, appointed to Amarin Board effective January 9, 2023.
- Stewart brings 30+ years cardiometabolic experience; formerly CMO at GSK and Rhythm Pharmaceuticals.
- Approximately 75% of independent directors are new, with six appointments over the past 12 months.
- Stewart will serve until 2023 AGM and then stand for election by shareholders.
- He will receive standard non-employee director equity awards and annual fees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/897448/000119312523005176/0001193125-23-005176-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/897448/000119312523005176/d443545d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-005176

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer